Original Article

Process and Results of Implementing Disease Management Program in Patients with First-time Ischemic Stroke


Background: This study aimed to examine the effect of disease management program (DMP) on the patients with first-time ischemic stroke (IS).

Methods: A DMP with 4 parts of performance indicators (PIs, including outpatient, emergency department, inpatient and follow-up treatment) was implemented in patients with stroke in 2 hospitals (Hospital T and R) in Shanghai China from 2007-2010. The effect of DMP on the outcome of IS patients was analyzed according to the criteria of the National Institute of Health Stroke Scale (NIHSS). Furthermore, the total effective rate of DMP, average length of stay, hospitalization cost, and cost-effectiveness ratio (CER) between DMP and non-DMP patients were calculated, followed by the cost-effectiveness analysis.

Results: The total effective rate of DMP (T: 69.9%; R: 76.6%) was significantly (P<0.05) higher than that of non-DMP (T: 60.8%; R: 62.7%) group in the same hospital. In addition, a significant (P<0.05) difference in effective rate was observed between DMP and non-DMP at the NIHSS score ≥ 7. Furthermore, the average length of stay and hospitalization cost of the patients in DMP group were significantly (P<0.05) lower than those in non-DMP group. A superior CER was also found in DMP group than non-DMP group.

Conclusion: The implementation of DMP for IS can effectively improve the treatment outcome and reduce the average length of stay and hospitalization cost.


Murray CJ, Lopez AD (2013). Measuring the global burden of disease. N Engl J Med, 369 (5): 448-57.

Jia Q, Liu LP, Wang YJ (2010). Stroke in China. Clin Exp Pharmacol Physiol, 37 (2): 259-64.

Lloyd-Jones D, Adams RJ, Brown TM, et al (2010). Heart disease and stroke statistics—2010 update A report from the American Heart Association. Circulation, 121(7): e46-e215.

Ontario HQ (2012). Specialized community-based care: an evidence-based analysis. Ont Health Technol Assess Ser, 12 (20): 1-60.

Sidorov J, Shull R, Tomcavage J et al (2002). Does diabetes disease management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization–sponsored disease management program among patients fulfilling health employer data and information set criteria. Diabetes Care, 25 (4): 684-689.

Joshi MS, Bernard DB (1999). Clinical performance improvement series. Classic CQI integrated with comprehensive disease management as a model for performance improvement. Jt Comm J Qual Improv, 25 (8): 383-95.

Velasco-Garrido M, Busse R, Hisashige A (2003). Are disease management programmes (DMPs) effective in improving quality of care for people with chronic conditions? http://www.euro.who.int/__data/assets/pdf_file/0020/74720/E82974.pdf

Krumholz HM, Amatruda J, Smith GL et al (2002). Randomized trial of an education and support intervention to preventreadmission of patients with heart failure. J Am Coll Cardiol, 39 (1): 83-89.

LaBresh KA, Reeves MJ, Frankel MR, Albright D, Schwamm LH (2008). Hospital treatment of patients with ischemic stroke or transient ischemic attack using the “Get With The Guidelines” program. Arch Intern Med, 168 (4): 411-17.

Lyden PD, Lu M, Levine SR et al (2001). A modified national institutes of health stroke scale for use in stroke clinical trials preliminary reliability and validity. Stroke, 32 (6): 1310-1317.

Adams H, Adams R, Del Zoppo G et al (2005). Guidelines for the Early Management of Patients With Ischemic Stroke 2005 Guidelines Update A Scientific Statement From the Stroke Council of the American Heart Association/American Stroke Association. Stroke, 36 (4): 916-923.

Gandjour A (2010). A model to predict the cost-effectiveness of disease management programs. Health Econ, 19 (6): 697-715.

Doan QV, Gillard P, Brashear A et al (2013). Cost-effectiveness of onabotulinumtoxinA for the treatment of wrist and hand disability due to upper-limb post-stroke spasticity in Scotland. Eur J Neurol, 20 (5): 773-780.

Hollenbeak CS, Boltz MM, Wang L et al (2011). Cost-effectiveness of the National Surgical Quality Improvement Program. Ann Surg, 254 (4): 619-624.

Gravely S, Reid RD, Oh P et al (2012). A prospective examination of disease management program use by complex cardiac outpatients. Can J Cardiol, 28 (4): 490-496.

Schafer I, Kuver C, Gedrose B et al (2010). The disease management program for type 2 diabetes in Germany enhances process quality of diabetes care - a follow-up survey of patient's experiences. BMC Health Serv Res, 10: 55.

Jaarsma T, van der Wal MH, Lesman-Leegte I, et al (2008). Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med, 168 (3): 316-324.

Kong L, Hu S (2005). Report on cardiovascular disease in China. Beijing: Encyclopedia of China Publishing House, pp.: 86-88.

Adams HP, Brott TG, Furlan AJ, et al (1996). Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke a statement for healthcare professionals from a special writing group of the stroke council, American heart association. Stroke, 27(9):1711-8.

Gladstone DJ, Rodan LH, Sahlas DJ, et al (2009). A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke, 40 (12): 3841-4.

Dartmouth-Hitchcock Medical Center (2010). http://med.dartmouth-hitchcock.org/documents/surgery_report_2010.pdf

Knox D, Mischke L (1999). Implementing a congestive heart failure disease management program to decrease length of stay and cost. J Cardiovasc Nurs, 14 (1): 55-74.

Lorig KR, Sobel DS, Stewart AL, et al (1999). Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care, 37 (1): 5-14.

Lorig KR, Sobel DS, Ritter PL et al (2001). Effect of a self-management program on patients with chronic disease. Eff Clin Pract, 4 (6): 256-262.

Badamgarav E, Weingarten SR, Henning JM et al (2003). Effectiveness of disease management programs in depression: a systematic review. Am J Psychiatry, 160 (12): 2080-2090.

Galbreath AD, Krasuski RA, Smith B et al (2004). Long-term healthcare and cost out-comes of disease management in a large, ran-domized, community-based population with heart failure. Circulation, 110 (23): 3518-26.

IssueVol 47 No 7 (2018) QRcode
SectionOriginal Article(s)
Disease management program Ischemic stroke Average length of stay Cost-effectiveness analysis

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
YANG H-R, MA L, JIANG Y-F, WU Y-C, C. LAI E, ZHU Y-H. Process and Results of Implementing Disease Management Program in Patients with First-time Ischemic Stroke. Iran J Public Health. 2018;47(7):1007-1016.